BeOne Medicines Ltd.
Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –
BeOne Medicines Non-GAAP Adjusted Basic Earnings per Ordinary Share by Year
Non-GAAP Adjusted Basic Earnings (Loss) per Ordinary Share ($/sh) ($)
BeOne Medicines Non-GAAP Adjusted Basic Earnings per Ordinary Share: $0.65 in FY2025, down 1,725.0% from a year earlier.
Where the FY2025 figure comes from
“|| Adjusted earnings (loss) per share - basic | $ | 0.16 | $ | 0.01 | $ | 0.65 | $ | (0.04)”
Source: Form 8-K (filed 2026-02-26) ↗
Reported in Form 8-K EX-99.1 Non-GAAP Reconciliation Tables.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Non-GAAP Adjusted Basic Earnings (Loss) per Ordinary Share ($/sh) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0.65 | -1,725.0% | Form 8-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | -0.04 | – | Form 8-K (filed 2026-02-26) ↗ |
Cite this data
StockData. (2026). BeOne Medicines Non-GAAP Adjusted Basic Earnings per Ordinary Share ($), annual FY2024–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/adj-eps-basic
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.